I agree with Jessica. As I mentioned in my speaking notes, Canada has really led the world in a lot of gynecologic cancer research and a lot of effective prevention and diagnostics. Endometrial cancer molecular classification started here. Opportunistic salpingectomy started here. With HPV-based screening, we're out ahead again. I think in that sense, we're not missing anything that's been done in other countries, but sometimes other countries have been more effective in ensuring equitable uptake and access.
On February 12th, 2024. See this statement in context.